CNMD
NYSECONMED Corporation
Price$36.92+1.06 (+2.97%)
02:00 PM07:45 PM
News · 26 weeks47+333%
2025-12-142026-06-07
Mix2890d
- Insider14(50%)
- SEC Filings8(29%)
- Other2(7%)
- Earnings2(7%)
- Analyst1(4%)
- Leadership1(4%)
Latest news
25 items- SECCONMED Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - CONMED Corp (0000816956) (Filer)
- INSIDERDirector Bronson David M. converted options into 668 shares, increasing direct ownership by 4% to 17,909 units (SEC Form 4)4 - CONMED Corp (0000816956) (Issuer)
- INSIDERDirector Council Laverne H converted options into 668 shares, increasing direct ownership by 17% to 4,716 units (SEC Form 4)4 - CONMED Corp (0000816956) (Issuer)
- INSIDERSEC Form 4 filed by Director Kelderman Kim4 - CONMED Corp (0000816956) (Issuer)
- INSIDERDirector Farkas Charles converted options into 668 shares, increasing direct ownership by 4% to 15,527 units (SEC Form 4)4 - CONMED Corp (0000816956) (Issuer)
- INSIDERDirector Kaye Mark converted options into 668 shares, increasing direct ownership by 439% to 820 units (SEC Form 4)4 - CONMED Corp (0000816956) (Issuer)
- INSIDERDirector Schwarzentraub Barbara J converted options into 668 shares, increasing direct ownership by 15% to 5,012 units (SEC Form 4)4 - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: New insider Lockwood Kimberly claimed ownership of 1,868 shares (SEC Form 3)3/A - CONMED Corp (0000816956) (Issuer)
- INSIDERNew insider Lockwood Kimberly claimed ownership of 1,868 shares (SEC Form 3)3 - CONMED Corp (0000816956) (Issuer)
- SECCONMED Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - CONMED Corp (0000816956) (Filer)
- SECSEC Form SD filed by CONMED CorporationSD - CONMED Corp (0000816956) (Filer)
- SECCONMED Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits8-K - CONMED Corp (0000816956) (Filer)
- PRCONMED Corporation Appoints Celine Martin and Jeff Mirviss to its Board of DirectorsCONMED Corporation (NYSE:CNMD) today announced the appointment of Celine Martin and Jeff Mirviss to its Board of Directors ("Board"), effective July 1, 2026. Ms. Martin will serve as a member of the Audit Committee and the Strategy Committee, and Mr. Mirviss will serve as a member of the Compensation Committee and the Corporate Governance and Nominating Committee. In connection with these appointments, CONMED is increasing the size of its Board to include a total of nine directors. "My fellow directors and I are delighted to welcome Celine Martin and Jeff Mirviss to the Board, both highly accomplished leaders with extensive experience developed at two of the largest companies in the healt
- SECSEC Form 10-Q filed by CONMED Corporation10-Q - CONMED Corp (0000816956) (Filer)
- SECCONMED Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CONMED Corp (0000816956) (Filer)
- PRCONMED Corporation Announces First Quarter 2026 Financial ResultsCONMED Corporation (NYSE:CNMD) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights Sales of $317.0 million decreased 1.3% year-over-year as reported and 2.9% in constant currency. Net sales growth was impacted by a $15.5 million decrease in sales from the exit of certain GI products. Domestic revenue decreased 5.8% year-over-year. Domestic sales growth was impacted by a $15.2 million decrease in sales from the exit of certain GI products. International revenue increased 4.7% year-over-year as reported and 1.0% in constant currency. International sales growth was impacted by a $0.3 million decrease in sales from the exit of c
- SECSEC Form DEFA14A filed by CONMED CorporationDEFA14A - CONMED Corp (0000816956) (Filer)
- SECSEC Form DEF 14A filed by CONMED CorporationDEF 14A - CONMED Corp (0000816956) (Filer)
- INSIDERSEC Form 4 filed by Beyer Pat4 - CONMED Corp (0000816956) (Issuer)
- PRCONMED Corporation to Announce First Quarter 2026 Financial Results on April 29, 2026CONMED Corporation (NYSE:CNMD) today announced that it will report financial results for the first quarter 2026 after the market close on Wednesday, April 29, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed from the "Investors" section of CONMED's website at www.conmed.com. The webcast replay of the call will be available at the same site approximately one hour after the end of the call. About CONMED Corporation CONMED is a medic
- SECAmendment: SEC Form SCHEDULE 13G/A filed by CONMED CorporationSCHEDULE 13G/A - CONMED Corp (0000816956) (Subject)
- INSIDERAmendment: SEC Form 4 filed by Lalomia Brent4/A - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Schabacker Matthew4/A - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Foust Hollie K4/A - CONMED Corp (0000816956) (Issuer)
- INSIDERAmendment: SEC Form 4 filed by Ferrell John D.4/A - CONMED Corp (0000816956) (Issuer)
CNMD FAQ
7 questionsWhat does CONMED Corporation do?
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries; sports...Where does CNMD stock trade?
CONMED Corporation (CNMD) is listed on NYSE.What sector and industry is CNMD in?
CONMED Corporation operates in the Health Care sector, Biotechnology: Electromedical & Electrotherapeutic Apparatus industry.When did CONMED Corporation go public?
CONMED Corporation (CNMD) completed its IPO in 1987.What are analysts saying about CNMD?
CONMED Corporation has had 8 recent analyst actions on file. The most recent action was from Piper Sandler: Neutral with a $3900.00 price target on 2026-03-17. Recent price targets cluster around $3900.00.What companies are similar to CNMD?
Notable peers in the same industry include MDT (Medtronic plc.), MASI (Masimo Corporation), SEAS (SeaWorld Entertainment Inc.), LIVN (LivaNova PLC), ITGR (Integer Holdings Corporation). Compare CNMD side-by-side with any of them on Quantisnow.How can I track CNMD on Quantisnow?
Quantisnow aggregates CONMED Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CNMD to receive live email and push alerts on every new disclosure.